Evan Unger
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.7MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 15, 2023 | NIH | SBIR Phase II Dodecafluoropentane emulsion (DDFPe), NanO2™ as Cerebroprotectant in Ischemic Stroke | $301K | NUVOX PHARMA, L.L.C. |
| Sep 15, 2021 | NIH | STTR Phase I NanO2 as a Cerebroprotectant in a tMCAO Stroke Model in Mice | $478K | NUVOX PHARMA, L.L.C. with UNIVERSITY OF ARIZONA |
| Dec 1, 2017 | NIH | SBIR Phase I Development of a syringe/sonication device employed to administer DDFPe in the prehospital setting | $144K | NUVOX PHARMA, L.L.C. |
| Sep 12, 2017 | NIH | SBIR Phase II Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma | $2.5M | NUVOX PHARMA, L.L.C. |
| Apr 1, 2017 | NIH | SBIR Phase I Dodecafluoropentane Prevents Ischemia Reperfusion Injury in Contemporary Acute Myocardial Infarction Management | $318K | NUVOX PHARMA, L.L.C. |
Peer ranks
Federal funding#436
Awards as PI#417
Patents#273
Companies
- NUVOX PHARMA, L.L.C.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.